本页面由Tiger Trade Technology Pte. Ltd.提供服务

4D Molecular Therapeutics

9.48
-0.3900-3.95%
盘后9.480.00000.00%18:27 EDT
成交量:70.69万
成交额:674.97万
市值:4.84亿
市盈率:-3.92
高:9.83
开:9.50
低:9.38
收:9.87
52周最高:12.34
52周最低:2.24
股本:5,100.79万
流通股本:3,678.36万
量比:0.60
换手率:1.92%
股息:- -
股息率:- -
每股收益(TTM):-2.4186
每股收益(LYR):-2.4200
净资产收益率:-27.57%
总资产收益率:-17.34%
市净率:0.96
市盈率(LYR):-3.92

数据加载中...

2024/08/09

重要事件披露

Form 8-K - Current report
2024/07/23

重要事件披露

Form 8-K - Current report
2024/07/17

重要事件披露

Form 8-K - Current report
2024/07/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/24

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/09

重要事件披露

Form 8-K - Current report